Sung Heon Kim

Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma

D. Nam, S. Hong, Y. Shin, 2018, Neuro-oncology.

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy

Kyoung-Mee Kim, Raul Rabadan, Donggeon Kim, 2018, Nature Genetics.

Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target

R. Rabadán, H. Seol, Jung-Il Lee, 2019, Experimental & Molecular Medicine.

Involvement of DDX6 gene in radio- and chemoresistance in glioblastoma.

Patrick J. Paddison, D. Nam, P. Paddison, 2016, International journal of oncology.

Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme

Hee Jin Cho, Do-Hyun Nam, D. Nam, 2015, Oncotarget.